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Abstracts / Osteoarthritis and Cartilage 21 (2013) S63–S312S70Purpose: Several predictive animal models have been developed for
human osteoarthritis (OA) and used to study the preclinical in vivo
efﬁcacy of disease-modifying OA drugs (DMOADs). In these studies, the
preclinical efﬁcacy has been determined by using various microscopic
scoring systems. Recently, the OARSI histopathology initiative pre-
sented recommendations for histological OA assessment in different
species in order to standardize preclinical efﬁcacy studies. In this study,
we performed a systemic characterization of knee joints in four rat OA
models by using OARSI rat scoring system in association with the
assessment of OA-related joint pain.
Methods: The studywas conducted usingmale Lewis rats. Unilateral OA
was induced in knee joints at 3 months of age by applying the following
rat OA models: 1) intra-articular injection of monoiodoacetate (MIA) at
the dose of 1 mg/kg, 2) medial meniscal tear (MMT) combined with
medial collateral ligament transection (MCLT), 3) anterior cruciate
ligament transection (ACLT) combined with partial medial meniscec-
tomy (pMMx), 4) ACLT. Body weight, static weight bearing determined
as hind paw weight distribution, and static mechanical allodynia
determined as paw withdrawal threshold were followed in each model
during the study. Knee joints were harvested and digital radiographs
were obtained from them at two different time points in each model as
follows: in the MIA model at 2 and 4 weeks, in the MMT + MCLT model
at 3 and 6 weeks, in the ACLT + pMMx model at 4 and 8 weeks, and in
the ACLT model at 5 and 10 weeks. Microscopic assessment of degen-
erative changes was performed in knee joints as recommended by the
OARSI histopathology initiative.
Results: Static weight bearing was decreased in operated knee joints
during the ﬁrst week of the study, demonstrating an operation-related
joint discomfort. Paw withdrawal threshold was decreased in operated
and MIA-injected knee joints during the ﬁrst week and at the end of the
study, indicating operation and OA-related joint pain. Microscopic
assessment of OA demonstrated progressive degenerative changes in
knee joints in all animal models. Mild to moderate changes were
observed in the MIA and ACLT models. In the MIA model, mild degen-
erative changes included the loss of chondrocytes, proteoglycans (PG)
and collagen matrix in superﬁcial layer of articular cartilage in medial
tibial plateau at 2 weeks, and the chondrocyte and PG loss exacerbated
down to intermediate layer at 4weeks. In the ACLTmodel, chondrocytes,
PG and collagen matrix were lost mainly in superﬁcial layer at 5 weeks,
their loss exacerbated down to tidemark at 10weeks, and these changes
were associatedwith the presence of moderate to large osteophytes and
minimal synovial inﬂammation. The MMT + MCLT and ACLT + pMMx
models exhibited moderate to severe degenerative changes. In the
articular cartilage ofmedial tibial plateau, chondrocytes, PG and collagen
matrix were lost from superﬁcial layer down to tidemark in the MMT +
MCLTmodel at 3 and 6weeks, and in the ACLT + pMMxmodel at 4 and 8
weeks. These changes were associated with the presence of large
osteophytes and mild synovial inﬂammation in both models.
Conclusions: This study characterized progressive degenerative
changes as recommended by the OARSI histopathology initiative in
knee joints of four rat OA models used frequently in the preclinical in
vivo efﬁcacy studies of DMOADs. Mild to moderate degenerative
changes were observed in the MIA and ACLT models and moderate to
severe changes in the MMT + MCLT and ACLT + pMMx models. In all OA
models, the development of degenerative changes was associated with
decreased paw withdrawal threshold, indicating OA-related joint pain.
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OLIGOMYCIN, AN INHIBITOR OF COMPLEX V OF MITOCHONDRIAL
RESPIRATORY CHAIN, INDUCES AN INFLAMMATORY RESPONSE IN
RAT KNEE JOINT
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M. Valcárcel-Ares, L. Hermida-Carballo, F. Blanco, M. López-
Armada. INIBIC, A Coruña, Spain
Purpose: A decline of mitochondrial function has been described in OA
chondrocytes and RA synoviocytes. Recent ex vivo ﬁndings support
a connection between mitochondrial dysfunction and activation of
inﬂammatory and destructive pathways in these cells. The aim of this
study was to investigate in vivo articular model if the intraarticular
injection of oligomycin, an inhibitor of mitochondrial function, induces
a destructive and inﬂammatory response in rat knee joints.
Methods: 24 female wistar rats (180-220g) was divided into three study
groups: Healthy (no intraarticular injection); Lipopolysaccharide (LPS)-
treated, positive control (left joint injected with: LPS 10ug and rightjoint with vehicle); and Oligomycin (OLI)-treated (left joint injected
with Oligomycin 20ug and right joint with vehicle). Three intraarticular
injections were carried out at days 0, 2 and 5. Rats were sacriﬁced at day
6, hind paws were collected and joint tissues were obtained.
Measurement of joint diameters on stimulis- and control-injected paws
was performed at days 0 and 6. Histopathologic lesions were evaluated
by hematoxilyn-eosin (H&E) and masson trichromic stain sections in
synovial tissue and by safranin O staining in cartilage. By RT-PCR, CINC-
1, IL-1b, CCL-2 and TNF-a gene expression were analyzed in extracted
cartilage. And by immunohistochemical staining, IL-8, equivalent of
CINC-1, expression was localized in the joint tissue.
Results: OLI-treated hind paws signiﬁcantly increased the joint diam-
eter (0.90.1 mm, n¼8, p<0.05, vs vehicle-injected joints), similarly to
LPS-treated (20.3 mm, n¼8, p<0.05, vs vehicle-injected joints). In
relation, histological evaluation of synovial tissue by H&E staining
revealed that joints treated with mitochondrial inhibitor present
greater synovial lining hyperplasia, proliferation of subsynovial tissue
and inﬁltration of a marked number of inﬂammatory cells while the
right control synovial only contained a moderate synovial proliferation
and inﬂammation (3.30.1 vs. 2.10.2, respectively, n¼8, p<0.001, vs
vehicle-injected joints). Besides, immunohistochemical studies on IL-8
showed a greater expression in synovial tissue from OLI-injected joints
versus those from vehicle-injected joints, coinciding with a strong
neutrophils inﬁltration. In relation to cartilage, when the loss of matrix
in the cartilage by safranin O stainingwas evaluated no differences were
observed, neither when IL-8 immunoperoxidase staining was per-
formed in cartilage. By contrast, when CINC-1 mRNA was analyzed in
this tissue, it was detected a signiﬁcant increment in OLI-injected joint
(n¼8, p<0.05 vs. vehicle-injected joint), similarly to LPS-treated.
Conclusions: The data seems to support that a loss of mitochondrial
function in the joint could participate in rheumatoid pathology through
generating an inﬂammatory response in the articular tissue, contrib-
uting to the perpetuation of joint injury.
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EXPRESSION OF PPAR A, B, G, AND H-AND L-PGDS DURING
OSTEOARTHRITIS IN THE SPONTANEOUS HARTLEY GUINEA PIG
AND THE EXPERIMENTAL DOG MODELS
S.-S. Nebbaki y, F.E.L Mansouri y, H. Aﬁf y, M. Kapoor y, M. Mohamed
Benderdour z, J.-P. Pelletier y, J. Martel-Pelletier y, H. Fahmi y. yCR-
CHUM, Notre Dame Hosp., Montreal, QC, Canada; zCR-CHUM, Hôpital
Sacré-Coeur de Montréal, Montreal, QC, Canada
Purpose: To investigate the expression of peroxisome proliferator-
activated receptor (PPAR) a, b, g, and hematopoietic and lipocaline-type
prostaglandin D synthase (H- and L-PGDS) over the course of osteoar-
thritis (OA) in the spontaneous Hartely guinea pig and the anterior
cruciate ligament transection dog models.
Methods:Guinea pigswere sacriﬁced at 2 (control group), 4, 8, and 12 (n
¼ 5 per group)months of age. Non-operated (control) and operated dogs
were sacriﬁed at 4, 8 and 12weeks post-surgery. Cartilagewas evaluated
histologically using the Osteoarthritis Research Society International
(OARSI) guidelines. The expression of PPARa, b, g, and H- and L-PGDS
were evaluated by real-time PCR and immunohistochemistry. The non-
parametric Spearman test was used for correlation analysis.
Results: PPARa, b and g were detected in medial tibial plateau from
control animals in both the spontaneous and surgical models. The levels
of PPARa and b did not change over the course of OA, whereas PPARg
levels decreased during the progression of the disease. We also showed
that the expression of H-PGDS remained unchanged, whereas that of L-
PGDS increased over the course of OA. PPARg levels correlated nega-
tively, whereas L-PGDS levels correlated positively, with the histological
score of OA.
Conclusion: The level of PPARg decreased, whereas that of L-PGDS
increased during the progression of OA. These data suggest that reduced
expression of PPARg may contribute to the pathogenesis of OA, whereas
enhanced expression of L-PGDS may be part of a reparative process.115
INITIATIONANDPROGRESSIONOFOCHRONOTICOSTEOARTHROPATHY
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